Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Analytical Biochemistry|March 23, 2004
A fluorogenic substrate for detection of organophosphatase activitySerguei Soukharev, David J Hammond
Analytical Biochemistry|April 3, 2007
Functional identification of novel activities: activity-based selection of proteins from complete proteomesJolly Sarkar, Serguei Soukharev, Julia Tait Lathrop, et al.
The Biochemical Journal|May 2, 2002
Uromodulin promoter directs high-level expression of biologically active human alpha1-antitrypsin into mouse urineHalina M Zbikowska, Nadia Soukhareva, Reza Behnam, et al.
Electrophoresis|March 11, 2003
Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob diseaseLarisa Cervenakova, Paul Brown, Serguei Soukharev, et al.
Transgenic Research|September 6, 2002
The use of the uromodulin promoter to target production of recombinant proteins into urine of transgenic animalsHalina M Zbikowska, Nadia Soukhareva, Reza Behnam, et al.
Blood Cells, Molecules & Diseases|June 18, 2002
Expression of factor VIII in recombinant and transgenic systemsSerguei Soukharev, David Hammond, Natalya M Ananyeva, et al.
Clinical Colorectal Cancer|September 5, 2016
Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal AdenocarcinomasMichael Pishvaian, Michael A Morse, Jennifer McDevitt, et al.
Journal for Immunotherapy of Cancer|February 11, 2026
Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumorsJohn L Villano, Jason J Luke, Ricklie Julian, et al.
International Journal of Oncology|February 14, 2012
MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft modelsChing Ching Leow, Karen Coffman, Ivan Inigo, et al.
Clinical Pharmacology and Therapeutics|July 21, 2020
Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development ParadigmVijayalakshmi Chelliah, Georgia Lazarou, Sumit Bhatnagar, et al.
Pageof 1